OQROSign up free
Insider trade

Rapport Therapeutics (RAPP): Director bought ~$100K

Wendy B. Young, Director at Rapport Therapeutics, bought ~$100K of Rapport Therapeutics shares.

~$100K
Approx. value · 3,789 sh @ $26.39
13K
Holds after · shares reported
Traded
Oct 22, 2026
Filed
Oct 22, 2026

Context

Written by software from the filings listed below · Oct 23, 2026

  • What was filed. Wendy B. Young, Director, reported an open-market purchase of about $100K of Rapport Therapeutics (RAPP) shares: 3,789 shares at $26.39 each. The Form 4 was filed on Oct 22, 2026, the transaction date. SEC Form 4

5 more points, with the facts they come from, are in OQRO Pro.

Sign up free

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 23, 2026Insider · 1 personInsiders: 3 sales (~$87K)
  2. Sep 30, 2026Insider · 1 personInsiders: 2 sales (~$332K)
  3. Oct 6, 2026InsiderCEO sold ~$108K of RAPP shares in the open market
  4. Oct 7, 2026InsiderCEO sold ~$35K of RAPP shares in the open market
  5. Oct 21, 2026Insider · 2 peopleInsiders: 1 purchase (~$144K), 1 sale (~$64K)
  6. Oct 22, 2026 · this disclosureInsider · 6 days before resultsDirector purchased ~$100K of RAPP shares in the open market

What came next

  1. Oct 22, 2026Insider · 3 peopleInsiders: 4 purchases (~$1.3M)
  2. Oct 23, 2026Insider · 5 days before resultsDirector purchased ~$98K of RAPP shares in the open market
  3. Oct 28, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
  4. Oct 28, 2026Insider · 1 personInsiders: 4 purchases (~$20.4M)
  5. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rapport Therapeutics

For Rapport Therapeutics, OQRO holds 20 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RAPP page.

Other recent filings by Wendy B. Young, Director

The full history of Wendy B. Young, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Rapport Therapeutics

Everything OQRO holds on this company is on its RAPP page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data